Induction chemotherapy before chemoradiotherapy and surgery for locally advanced rectal cancer : is it time for a randomized phase III trial?

  • Claus Rödel
  • Dirk Arnold
  • Heinz Becker
  • Rainer Fietkau
  • Michael Ghadimi
  • Ullrich Graeven
  • Clemens Hess
  • Ralf Hofheinz
  • Werner Hohenberger
  • Stefan Post
  • Rudolf Raab
  • Rolf Sauer
  • Frederick Wenz
  • Torsten Liersch

Abstract

in the era of preoperative chemoradiotherapy (CRT) and total mesorectal excision (TME), the development of distant metastases is the predominant mode of failure in rectal cancer patients today. Integrating more effective systemic therapy into combined modality programs is the challenge. The question that needs to be addressed is how and when to apply systemic treatment with adequate dose and intensity.

Bibliographical data

Original languageGerman
Article number12
ISSN0179-7158
Publication statusPublished - 2010
pubmed 21136027